Life/Health Insurance Plunge: Dive -2.99%! $CNO, $UNM, $AFL, $AEL, $MFC and More!
Life/Health Insurance Stocks Experience a 2.99% Decline!
📉 Intro Description:
Life/Health insurance stocks are under pressure, seeing a loss of nearly 3%. With a "Strong Sell" rating backing most stocks in this category, traders need to exercise caution. A deeper dive will provide a better understanding of individual stocks and market movements.
📉 Life/Health Insurance Sector Faces Challenges with a -2.99% Loss, but AI Robots Can Help You Minimize Losses! 🤖📈
With AI-powered tools at your disposal, you can better navigate the Life/Health Insurance sector, mitigate potential losses, and make data-driven choices.
📊 "Swing Trader, Long Only: Valuation & Efficiency Model (TA&FA)" offers a strategic approach to valuation and efficiency within the sector. By leveraging AI insights, you can make more informed decisions and optimize your trading within this space.
🌟 "Swing Trader, Long Only: Valuation & Seasonality Model (TA&FA)" takes into account seasonality trends, allowing you to adjust your strategy based on historical patterns.
Stay ahead of market fluctuations with AI precision! 💼📊🌟
Tickers of this Group:
$CNO $UNM $AFL $AEL $MFC $PRU $MET $GNW $PUK $LNC $PRI $NWLI $BHF $FG $GL $ABL $BHFAN $BHFAO $BHFAP $JXN $BHFAM
🏢 Industry Description:
Life insurance companies offer policies that pay beneficiaries a lump sum upon the insured's death. These policies can be term or whole life. Life insurance firms might also provide long-term disability policies to replace income if the insured becomes sick or disabled. Health insurance helps cover medical expenses. Major players include Anthem, Inc., MetLife, Inc., and Aflac Incorporated.
📊 Market Cap:
The average market cap across this industry is 14.1B. Topping the list is $MET with a valuation of 46.4B, while $BHFAN stands at the lower end with zero.
📈 High and Low Price Notable News:
Price growth in the last week was -3.31% on average across all stocks in the sector. Monthly and quarterly price growth rates stand at -5.83% and 10.96% respectively. $ABL stands out with a positive growth of 2.36%, while $BHFAM declined the most, dropping 7.86%.
- News Flashes:
- $MET: Fell by 5.17% this week.
- $LNC: Dropped by a staggering 9.54% this week.
- $MFC: Experienced a decline of 5.56% this week.
🔊 Volume:
Weekly volume growth averaged 8.92% across all stocks. Monthly and quarterly volume growth rates for the same set of stocks were 65.33% and 21.24% respectively.
- Volume Highlights:
- $CNO: Saw a record-breaking growth of 112% of the 65-Day Volume Moving Average.
- $AEL: Experienced a record-breaking daily growth of 300% of the 65-Day Volume Moving Average.
- $BHF: Recorded a record-breaking daily growth of 223% of the 65-Day Volume Moving Average.
📚 Fundamental Analysis Ratings:
- Valuation Rating: 53
- P/E Growth Rating: 42
- Price Growth Rating: 46
- SMR Rating: 95
- Profit Risk Rating: 69
- Seasonality Score: 46
🌐 Notable Companies:
Prominent companies in this industry include MetLife ($MET), Prudential Financial ($PRU), Lincoln National Corp ($LNC), and Genworth Financial ($GNW).
📜 Ticker Analysis:
$CNO:
MACD Analysis: Turned negative on October 03, 2023, indicating a potential decline with a probability of 71%.
Stock Forecast: Price of $23.05 is trading between resistance of $24.64 and support of $21.07. Price fell by 2% in the last month.
$UNM:
Moving Average Analysis: Fell below its 50-day Moving Average on October 03, 2023. A downward trend is probable with 76% chances.
Stock Forecast: Current price of $48.15 is trading between support of $48.26 and resistance of $40.99. Price declined by 2% over the last month.
$AFL:
Momentum Indicator Analysis: Moved below the 0 level on October 02, 2023, signaling a probable shift to a new downward trend. The historical trend shows a 56% chance of a further decline.
Stock Forecast: The current price of $76.07 has surpassed the resistance line at $64.00 and is trading between support at $97.03 and resistance at $64.00. Over the last month, the price showed a +1% Uptrend, but declined by 1% in the past week.
$AEL:
Momentum Indicator Analysis: The indicator moved below the 0 level on September 25, 2023. This suggests a potential downward trend. Historically, in similar scenarios, the stock declined 68% of the time.
Stock Forecast: Currently trading at $53.40, the stock has crossed its resistance of $50.98. It's now positioned between the $58.39 resistance and $50.98 resistance lines. The past month witnessed a slight downtrend of -0.95%, with the stock falling -0.90% in the last week.
$MFC:
Moving Average Analysis: The 50-day Moving Average for MFC crossed below its 200-day moving average on September 29, 2023. This is typically seen as a long-term bearish signal.
Stock Forecast: The current stock price of $17.68 is trading between support at $17.93 and resistance at $14.80. In the last month, there has been a -5% downtrend, and in the past week, the stock has declined by 5%.
$PRU:
Trend Analysis: PRU is in a 3.74% downward trend, witnessing decline for three consecutive days as of October 03, 2023. Historically, 65% of similar situations led to further declines in the following month.
Stock Forecast: PRU, priced at $91.17, has crossed its support line at $88.99. It currently trades between the resistance at $123.23 and support at $88.99. Over the last month, a -4% downtrend was observed, with a 4% decline in the last week.
$MET:
Moving Average Analysis: The stock moved below its 50-day Moving Average on September 27, 2023, suggesting a shift from an upward trend to a downward one. There's a 59% likelihood of the stock continuing this downward trend based on past data.
Stock Forecast: With a current price of $59.99, it is below the lowest support line of $65.15 defined by A.I. The past month saw a -5% decline, with a weekly decline of -4%.
$GNW:
Moving Average Analysis: As of October 03, 2023, GNW moved below its 50-day Moving Average, indicating a potential change from an upward trend to a downward one. Historically, the stock has decreased 85% of the time in such scenarios.
Stock Forecast: Trading at $5.88, the stock has crossed its support at $5.27. It's now between the support of $6.88 and $5.27. The past month witnessed a -2% decline, with a similar -2% decrease in the past week.
CNO in upward trend: 10-day moving average broke above 50-day moving average on July 03, 2025
The 10-day moving average for CNO crossed bullishly above the 50-day moving average on July 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 27, 2025. You may want to consider a long position or call options on CNO as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on June 23, 2025. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
CNO moved above its 50-day moving average on July 03, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .
CNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 70 cases where CNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.334) is normal, around the industry mean (1.496). P/E Ratio (11.333) is within average values for comparable stocks, (39.438). CNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.675). Dividend Yield (0.022) settles around the average of (0.124) among similar stocks. P/S Ratio (0.755) is also within normal values, averaging (2.172).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of health and life insurance services
Industry LifeHealthInsurance
Advertisement